Patents by Inventor Nicole Sunseri

Nicole Sunseri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric human immunodeficiency virus type 1 (HIV-1) with enhanced dendritic cell and macrophage tropism comprising the simian immunodeficiency virus (SIV) minimal Vpx packaging domain
    Patent number: 9149519
    Abstract: The compositions and methods described herein relate to lentiviral vectors that can be used to generate virions/viruses that exhibit enhanced infectivity with respect to monocyte-derived macrophages (MDM) and dendritic cells (MDDC). Such compositions and methods further relate to production of virions/viruses that can be used as components of vaccines that effectively stimulate innate immune responses. In a particular embodiment, compositions and methods described herein relate to production of virions/viruses that can be used as components of human immunodeficiency-1 (HIV-1) vaccines administered to stimulate innate immune responses to HIV-1.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: October 6, 2015
    Assignee: New York University
    Inventors: Nathaniel R. Landau, Nicole Sunseri, Thomas D. Norton
  • LENTIVIRAL VECTORS AND METHODS OF USE THEREOF
    Publication number: 20130183334
    Abstract: The compositions and methods described herein relate to lentiviral vectors that can be used to generate virions/viruses that exhibit enhanced infectivity with respect to monocyte-derived macrophages (MDM) and dendritic cells (MDDC). Such compositions and methods further relate to production of virions/viruses that can be used as components of vaccines that effectively stimulate innate immune responses. In a particular embodiment, compositions and methods described herein relate to production of virions/viruses that can be used as components of human immunodeficiency-1 (HIV-1) vaccines administered to stimulate innate immune responses to HIV-1.
    Type: Application
    Filed: January 17, 2013
    Publication date: July 18, 2013
    Inventors: Nathaniel R. Landau, Nicole Sunseri, Thomas D. Norton